InsidersTradesSigma
Follow the 엔솔바이오사이언스 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 엔솔바이오사이언스 has published 6 insider filings. Market capitalisation: €158.9bn. The latest transaction was filed on 19 March 2026 (Purchase). Among the most active insiders: 형인우. The full history is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations